当前位置: 首页 > 期刊 > 《中医药学刊》 > 2012年第1期 > 正文
编号:12179262
美沙拉嗪干预溃疡性结肠炎相关癌变小鼠的实验研究(3)
http://www.100md.com 2012年1月1日 殷汉华 张涛 李捷壮 温达雄
第1页

    参见附件。

     [5] 陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1991:1103.

    [6] Lukas M.Inflammatory bowel disease as a risk factor for colorectal cancer[J].Dig Dis,2010,28(4-5):619-24.

    [7] Schneikert J, Behrens J. The canonical Wnt signaling pathway and its APC partner in colon cancer development[J].Gut, 2007,56(3):417-425.

    [8] Colotta F, Allavena P, Sica A, et al.Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability[J].Carcinogenesis, 2009,30(7):1073-1081.

    [9] Gregorieff A, Pinto D, Begthel H, et al.Expression pattern of Wnt signaling components in the adult intestine[J].Gastroenterology, 2005,129(2):626-638.

    [10] Reya T, Clevers H.Wnt signaling in stem cells and cancer[J].Nature, 2005,434(7035):843-850.

    [11] Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer[J]. Genes Dev, 2005,19(8):877-890.

    [9] Higgins PD.New keys to maintenance treatment in ulcerative colitis[J].Dig Dis, 2010,28(3):483-489.

    [10] Lakatos L, Kiss LS, David G,et al.Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006 ......

您现在查看是摘要介绍页,详见PDF附件(2684kb)